CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 175 of 386 entries

View as:

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03189446 Org: User:

Start: 10/02/17 End: 10/06/21 Due: 10/06/22

Magnesphere for Autonomic Alteration

Phase: N/A Priority: Normal

NCT ID: NCT04207476 Org: User:

Start: 07/25/21 End: 10/12/22 Due: 10/12/23

Closure Method Study Following Tonsillectomy in Children

Phase: N/A Priority: Normal

NCT ID: NCT00730340 Org: User:

Start: 08/31/08 End: 06/30/10 Due: 06/30/11

Effects of Yoga on Bone Metabolism in Premenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT02163668 Org: User:

Start: 09/30/09 End: 04/30/12 Due: 04/30/13

Non-inflatable Supraglottic Airway (NI-SGA) vs. Face Mask (FM) as a Primary Interface Device for Neonatal Resuscitation

Phase: N/A Priority: Normal

NCT ID: NCT02629887 Org: User:

Start: 04/15/18 End: 04/15/18 Due: 04/15/19

Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction

Phase: N/A Priority: Normal

NCT ID: NCT03327649 Org: User:

Start: 12/12/17 End: 09/30/21 Due: 09/30/22

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

Phase: N/A Priority: Normal

NCT ID: NCT00582894 Org: User:

Start: 02/28/05 End: 03/31/08 Due: 03/31/09

The Effect of Intermittent Fasting on Brain Health

Phase: N/A Priority: Normal

NCT ID: NCT06019195 Org: User:

Start: 07/12/23 End: 07/31/26 Due: 07/31/27

Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia

Phase: N/A Priority: Normal

NCT ID: NCT00869375 Org: User:

Start: 04/30/09 End: 06/30/12 Due: 06/30/13

Development of Education Materials for Prevention of FAS in Russia

Phase: N/A Priority: Normal

NCT ID: NCT01971398 Org: User:

Start: 04/30/07 End: 12/31/07 Due: 12/31/08

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0

Phase: N/A Priority: Normal

NCT ID: NCT06488781 Org: User:

Start: 07/26/24 End: 12/31/28 Due: 12/31/29

PHF Problematic Sexual Behavior of Youth Family Engagement

Phase: N/A Priority: Normal

NCT ID: NCT04902287 Org: User:

Start: 10/13/21 End: 02/18/22 Due: 02/18/23

Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion

Phase: N/A Priority: Normal

NCT ID: NCT01349491 Org: User:

Start: 03/31/12 End: 06/30/14 Due: 06/30/15

Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females

Phase: N/A Priority: Normal

NCT ID: NCT00945594 Org: User:

Start: 07/31/09 End: 11/30/11 Due: 11/30/12

Compassionate Use of Omegaven in Children

Phase: N/A Priority: Normal

NCT ID: NCT02370251 Org: User:

Start: 06/30/15 End: 09/27/19 Due: 09/27/20

Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation

Phase: N/A Priority: Normal

NCT ID: NCT00999479 Org: User:

Start: 10/31/09 End: 10/31/11 Due: 10/31/12

Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00204386 Org: User:

Start: 09/30/02 End: 05/31/07 Due: 05/31/08

Study of Eribulin in Children With Cancer to Determine Safety

Phase: N/A Priority: Normal

NCT ID: NCT02082626 Org: User:

Start: 02/01/14 End: 06/30/18 Due: 06/30/19

Balance in Children With Cochlear Implants

Phase: N/A Priority: Normal

NCT ID: NCT00642343 Org: User:

Start: 03/31/08 End: 06/30/10 Due: 06/30/11

High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00584428 Org: User:

Start: 06/30/92 End: 03/31/02 Due: 03/31/03

Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study

Phase: N/A Priority: Normal

NCT ID: NCT02907866 Org: User:

Start: 09/30/16 End: 12/31/25 Due: 12/31/26

Osseodensification and Implant Survival and Success

Phase: N/A Priority: Normal

NCT ID: NCT04741594 Org: User:

Start: 07/01/21 End: 09/13/23 Due: 09/13/24

Aflibercept Injection for Proliferative Diabetic Retinopathy

Phase: N/A Priority: Normal

NCT ID: NCT01805297 Org: User:

Start: 03/31/13 End: 11/30/15 Due: 11/30/16

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03526432 Org: User:

Start: 08/08/18 End: 09/30/25 Due: 09/30/26

Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)

Phase: N/A Priority: Normal

NCT ID: NCT05617001 Org: User:

Start: 10/04/22 End: 12/31/24 Due: 12/31/25

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer	NCT03189446	University of Oklahoma	user2@example.com	None	2017-10-02	2021-10-06	2022-10-06	-	-	2025-07-14
Magnesphere for Autonomic Alteration	NCT04207476	University of Oklahoma	user2@example.com	None	2021-07-25	2022-10-12	2023-10-12	-	-	2025-07-14
Closure Method Study Following Tonsillectomy in Children	NCT00730340	University of Oklahoma	user2@example.com	None	2008-08-31	2010-06-30	2011-06-30	-	-	2025-07-14
Effects of Yoga on Bone Metabolism in Premenopausal Women	NCT02163668	University of Oklahoma	user2@example.com	None	2009-09-30	2012-04-30	2013-04-30	-	-	2025-07-14
Non-inflatable Supraglottic Airway (NI-SGA) vs. Face Mask (FM) as a Primary Interface Device for Neonatal Resuscitation	NCT02629887	University of Oklahoma	user2@example.com	None	2018-04-15	2018-04-15	2019-04-15	-	-	2025-07-14
Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction	NCT03327649	University of Oklahoma	user2@example.com	None	2017-12-12	2021-09-30	2022-09-30	-	-	2025-07-14
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases	NCT00582894	University of Oklahoma	user2@example.com	None	2005-02-28	2008-03-31	2009-03-31	-	-	2025-07-14
The Effect of Intermittent Fasting on Brain Health	NCT06019195	University of Oklahoma	user2@example.com	None	2023-07-12	2026-07-31	2027-07-31	-	-	2025-07-14
Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia	NCT00869375	University of Oklahoma	user2@example.com	None	2009-04-30	2012-06-30	2013-06-30	-	-	2025-07-14
Development of Education Materials for Prevention of FAS in Russia	NCT01971398	University of Oklahoma	user2@example.com	None	2007-04-30	2007-12-31	2008-12-31	-	-	2025-07-14
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0	NCT06488781	University of Oklahoma	user2@example.com	None	2024-07-26	2028-12-31	2029-12-31	-	-	2025-07-14
PHF Problematic Sexual Behavior of Youth Family Engagement	NCT04902287	University of Oklahoma	user2@example.com	None	2021-10-13	2022-02-18	2023-02-18	-	-	2025-07-14
Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion	NCT01349491	University of Oklahoma	user2@example.com	None	2012-03-31	2014-06-30	2015-06-30	-	-	2025-07-14
Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females	NCT00945594	University of Oklahoma	user2@example.com	None	2009-07-31	2011-11-30	2012-11-30	-	-	2025-07-14
Compassionate Use of Omegaven in Children	NCT02370251	University of Oklahoma	user2@example.com	None	2015-06-30	2019-09-27	2020-09-27	-	-	2025-07-14
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation	NCT00999479	University of Oklahoma	user2@example.com	None	2009-10-31	2011-10-31	2012-10-31	-	-	2025-07-14
Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder	NCT00204386	University of Oklahoma	user2@example.com	None	2002-09-30	2007-05-31	2008-05-31	-	-	2025-07-14
Study of Eribulin in Children With Cancer to Determine Safety	NCT02082626	University of Oklahoma	user2@example.com	None	2014-02-01	2018-06-30	2019-06-30	-	-	2025-07-14
Balance in Children With Cochlear Implants	NCT00642343	University of Oklahoma	user2@example.com	None	2008-03-31	2010-06-30	2011-06-30	-	-	2025-07-14
High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer	NCT00584428	University of Oklahoma	user2@example.com	None	1992-06-30	2002-03-31	2003-03-31	-	-	2025-07-14
Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study	NCT02907866	University of Oklahoma	user2@example.com	None	2016-09-30	2025-12-31	2026-12-31	-	-	2025-07-14
Osseodensification and Implant Survival and Success	NCT04741594	University of Oklahoma	user2@example.com	None	2021-07-01	2023-09-13	2024-09-13	-	-	2025-07-14
Aflibercept Injection for Proliferative Diabetic Retinopathy	NCT01805297	University of Oklahoma	user2@example.com	None	2013-03-31	2015-11-30	2016-11-30	-	-	2025-07-14
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer	NCT03526432	University of Oklahoma	user2@example.com	None	2018-08-08	2025-09-30	2026-09-30	-	-	2025-07-14
Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)	NCT05617001	University of Oklahoma	user2@example.com	None	2022-10-04	2024-12-31	2025-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance